However, other studies found that PD-L1 expression was positively correlated with the features of unfavorable outcomes, such as tumor size [124], proliferation index [124], high-risk GIST [125, 153] and therapy resistance [153], but was not associated with RFS [109], metastasis [124] and OS [105, 109, 124]. This evidence concerns the gene CD274 and neoplasm.